Prehistoric ancestor of leukaemia virus found in bats

Researchers identified the remnants of a deltaretrovirus in the genome of bent-winged bats

Immune system genes linked to most common type of leukaemia

Gene discovery could lead to new targeted treatments and boost immunotherapy

Veterans not at higher risk of leukaemia, finds study

Exposure to radiation and certain chemicals may increase the risk, leading to worries about the consequences of military service

Gene may worsen cancer outcome by speeding metabolism of drugs

The gene, called CYP3A7, is normally only active in infancy, but in some people it continues to be switched on into adulthood

Children from less-affluent backgrounds ‘more likely to die’ following treatment for leukaemia in the UK

Lack of adherence to complex treatment regimens may underpin the variations in survival rates by social groups

Patient trials of new leukaemia cancer vaccine

Treatment will use a new DNA vaccine which will treat a selected group of volunteers who have either chronic or acute myeloid leukaemia

Umbilical-cord blood units to treat leukaemia

Scientists have cleared a major technical hurdle to making umbilical-cord-blood transplants a more widely-used method for treating leukaemia and other blood cancers.

Helping older leukaemia patients

Older patients with acute myeloid leukaemia might benefit from a drug that reactivates genes that cancer cells turn off, according to research.

Protein linked to leukaemia bookmarks genes

Each cell inherits genes from its parent as well as epigenetic information - what amounts to an instruction manual that specifies which genes should be activated or 'expressed,' when and to what level.

Pair of genes cause aggressive leukaemia

New research carried out on gene-modified mice indicate that two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia.

New chromosomal abnormality identified in leukaemia

Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.

New treatment doubles childhood leukaemia survival

A study shows that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Pharmacology: New drug for children with high-risk leukaemia

The first researchers to discover a mutation of the JAK2 protein in patients with Down syndrome, a team of scientists suspected that this protein might also be linked to other disorders and diseases - and they were right.

Few genetic changes launch rare leukaemia

The most comprehensive analysis yet of the genome of childhood acute myeloid leukaemia found only a few mistakes in the genetic blueprint, suggesting the cancer arises from just a handful of missteps

Gene protects against leukaemia

Researchers have identified a gene that controls the rapid production and differentiation of the stem cells that produce all blood cell types.





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited